ExodusPoint Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

ExodusPoint Capital Management’s Portfolio SPRY Stock Details SPRY Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$318K	Sell
2025 Q1	$2.48M	Buy
2024 Q4	$260K	Buy
2024 Q1	–	Sell
2023 Q4	$208K	Buy
2023 Q3	$42K	Buy
2022 Q1	–	Sell
2021 Q4	$128K	Buy
2021 Q1	–	Sell
2020 Q4	$968K	Buy